PharmaCyte Biotech, Inc. (PMCB)
NASDAQ·Healthcare·Biotechnology
$0.77
+0.96%
Mkt Cap $4.76M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 17, 2026 | — | — | — | -$0.06 | $0.13 | +316.67% | — | — |
| Q4 2025 Dec 18, 2025 | — | — | — | — | -$0.32 | — | — | — |
| Q3 2025 Sep 15, 2025 | — | — | — | — | -$0.09 | — | — | — |
| Q3 2025 Aug 11, 2025 | — | — | — | — | $1.73 | — | — | — |
| Q1 2025 Mar 17, 2025 | — | — | — | — | -$0.10 | — | — | — |
| Q4 2024 Dec 13, 2024 | — | — | — | — | -$0.29 | — | — | — |
| Q3 2024 Sep 16, 2024 | — | — | — | — | $0.14 | — | — | — |
| Q3 2024 Aug 13, 2024 | — | — | — | — | -$0.85 | — | — | — |
| Q1 2024 Mar 18, 2024 | — | — | — | — | -$0.65 | — | — | — |
| Q4 2023 Dec 15, 2023 | — | — | — | — | -$0.64 | — | — | — |
| Q3 2023 Sep 18, 2023 | — | — | — | — | -$0.28 | — | — | — |
| Q3 2023 Jul 31, 2023 | — | — | — | -$0.09 | -$0.01 | +88.89% | — | — |
| Q1 2023 Mar 16, 2023 | — | — | — | -$0.08 | -$0.04 | +50.00% | — | — |
| Q4 2022 Dec 14, 2022 | — | — | — | -$0.08 | -$0.09 | -12.50% | — | — |
| Q3 2022 Sep 14, 2022 | — | — | — | -$0.07 | -$0.07 | +0.00% | — | — |
| Q3 2022 Jul 28, 2022 | — | — | — | -$0.03 | -$0.06 | -74.98% | — | — |
| Q1 2022 Mar 15, 2022 | — | — | — | -$0.05 | -$0.04 | +20.00% | — | — |
| Q4 2021 Dec 14, 2021 | — | — | — | -$0.07 | -$0.06 | +14.29% | — | — |
| Q3 2021 Sep 14, 2021 | — | — | — | — | -$0.64 | — | — | — |
| Q3 2021 Aug 10, 2021 | — | — | — | — | -$0.62 | — | — | — |